vs
Side-by-side financial comparison of ADAMAS TRUST, INC. (ADAM) and VIEMED HEALTHCARE, INC. (VMD). Click either name above to swap in a different company.
VIEMED HEALTHCARE, INC. is the larger business by last-quarter revenue ($76.2M vs $43.2M, roughly 1.8× ADAMAS TRUST, INC.). ADAMAS TRUST, INC. runs the higher net margin — 124.0% vs 7.4%, a 116.6% gap on every dollar of revenue. On growth, ADAMAS TRUST, INC. posted the faster year-over-year revenue change (61.6% vs 25.5%). ADAMAS TRUST, INC. produced more free cash flow last quarter ($125.9M vs $9.7M). Over the past eight quarters, ADAMAS TRUST, INC.'s revenue compounded faster (55.5% CAGR vs 22.7%).
Viemed Healthcare, Inc. is a medical technology firm specializing in respiratory care solutions. It develops, manufactures and distributes portable ventilators, respiratory therapy devices and related support services, catering to acute care, post-acute care and home care segments across North America, Europe and key Asia-Pacific markets for patients with respiratory conditions.
ADAM vs VMD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $43.2M | $76.2M |
| Net Profit | $53.5M | $5.6M |
| Gross Margin | — | 57.9% |
| Operating Margin | — | 11.0% |
| Net Margin | 124.0% | 7.4% |
| Revenue YoY | 61.6% | 25.5% |
| Net Profit YoY | 270.5% | 30.7% |
| EPS (diluted) | $0.45 | $0.14 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $43.2M | $76.2M | ||
| Q3 25 | $36.6M | $71.9M | ||
| Q2 25 | $36.4M | $63.1M | ||
| Q1 25 | $33.1M | $59.1M | ||
| Q4 24 | $26.7M | $60.7M | ||
| Q3 24 | $20.2M | $58.0M | ||
| Q2 24 | $19.0M | $55.0M | ||
| Q1 24 | $17.9M | $50.6M |
| Q4 25 | $53.5M | $5.6M | ||
| Q3 25 | $44.8M | $3.5M | ||
| Q2 25 | $8.5M | $3.2M | ||
| Q1 25 | $42.2M | $2.6M | ||
| Q4 24 | $-31.4M | $4.3M | ||
| Q3 24 | $42.8M | $3.9M | ||
| Q2 24 | $-15.6M | $1.5M | ||
| Q1 24 | $-57.9M | $1.6M |
| Q4 25 | — | 57.9% | ||
| Q3 25 | — | 57.5% | ||
| Q2 25 | — | 58.3% | ||
| Q1 25 | — | 56.3% | ||
| Q4 24 | — | 59.5% | ||
| Q3 24 | — | 59.3% | ||
| Q2 24 | — | 59.8% | ||
| Q1 24 | — | 58.9% |
| Q4 25 | — | 11.0% | ||
| Q3 25 | — | 7.8% | ||
| Q2 25 | 11.7% | 8.1% | ||
| Q1 25 | — | 6.5% | ||
| Q4 24 | -119.0% | 10.6% | ||
| Q3 24 | — | 9.7% | ||
| Q2 24 | -124.7% | 6.6% | ||
| Q1 24 | -448.8% | 4.4% |
| Q4 25 | 124.0% | 7.4% | ||
| Q3 25 | 122.5% | 4.9% | ||
| Q2 25 | 23.4% | 5.0% | ||
| Q1 25 | 127.4% | 4.4% | ||
| Q4 24 | -117.5% | 7.1% | ||
| Q3 24 | 211.7% | 6.7% | ||
| Q2 24 | -81.9% | 2.7% | ||
| Q1 24 | -324.1% | 3.2% |
| Q4 25 | $0.45 | $0.14 | ||
| Q3 25 | $0.36 | $0.09 | ||
| Q2 25 | $-0.04 | $0.08 | ||
| Q1 25 | $0.33 | $0.06 | ||
| Q4 24 | $-0.46 | $0.10 | ||
| Q3 24 | $0.36 | $0.10 | ||
| Q2 24 | $-0.29 | $0.04 | ||
| Q1 24 | $-0.75 | $0.04 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $210.3M | $13.5M |
| Total DebtLower is stronger | $735.8M | — |
| Stockholders' EquityBook value | $1.4B | $141.5M |
| Total Assets | $12.6B | $199.2M |
| Debt / EquityLower = less leverage | 0.52× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $210.3M | $13.5M | ||
| Q3 25 | $185.3M | $11.1M | ||
| Q2 25 | $160.4M | $20.0M | ||
| Q1 25 | $177.1M | $10.2M | ||
| Q4 24 | $167.4M | $17.5M | ||
| Q3 24 | $195.1M | $11.3M | ||
| Q2 24 | $235.5M | $8.8M | ||
| Q1 24 | $226.9M | $7.3M |
| Q4 25 | $735.8M | — | ||
| Q3 25 | $766.6M | — | ||
| Q2 25 | $653.0M | — | ||
| Q1 25 | $654.4M | — | ||
| Q4 24 | $573.2M | — | ||
| Q3 24 | $699.4M | — | ||
| Q2 24 | $800.7M | — | ||
| Q1 24 | $1.0B | — |
| Q4 25 | $1.4B | $141.5M | ||
| Q3 25 | $1.4B | $133.6M | ||
| Q2 25 | $1.4B | $139.7M | ||
| Q1 25 | $1.4B | $134.8M | ||
| Q4 24 | $1.4B | $131.4M | ||
| Q3 24 | $1.4B | $125.0M | ||
| Q2 24 | $1.4B | $119.4M | ||
| Q1 24 | $1.5B | $116.3M |
| Q4 25 | $12.6B | $199.2M | ||
| Q3 25 | $12.4B | $202.4M | ||
| Q2 25 | $10.6B | $184.6M | ||
| Q1 25 | $10.0B | $178.1M | ||
| Q4 24 | $9.2B | $177.1M | ||
| Q3 24 | $8.9B | $169.5M | ||
| Q2 24 | $8.2B | $163.9M | ||
| Q1 24 | $7.4B | $154.9M |
| Q4 25 | 0.52× | — | ||
| Q3 25 | 0.55× | — | ||
| Q2 25 | 0.47× | — | ||
| Q1 25 | 0.47× | — | ||
| Q4 24 | 0.41× | — | ||
| Q3 24 | 0.48× | — | ||
| Q2 24 | 0.56× | — | ||
| Q1 24 | 0.67× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $134.0M | $18.4M |
| Free Cash FlowOCF − Capex | $125.9M | $9.7M |
| FCF MarginFCF / Revenue | 291.6% | 12.7% |
| Capex IntensityCapex / Revenue | 18.9% | 11.5% |
| Cash ConversionOCF / Net Profit | 2.50× | 3.27× |
| TTM Free Cash FlowTrailing 4 quarters | — | $11.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $134.0M | $18.4M | ||
| Q3 25 | $6.9M | $18.4M | ||
| Q2 25 | $39.2M | $12.3M | ||
| Q1 25 | $25.8M | $2.9M | ||
| Q4 24 | $14.1M | $15.0M | ||
| Q3 24 | $-922.0K | $12.7M | ||
| Q2 24 | $-993.0K | $10.2M | ||
| Q1 24 | $-13.1M | $1.2M |
| Q4 25 | $125.9M | $9.7M | ||
| Q3 25 | — | $10.7M | ||
| Q2 25 | — | $4.1M | ||
| Q1 25 | — | $-12.6M | ||
| Q4 24 | $-10.6M | $3.2M | ||
| Q3 24 | $-8.6M | $1.7M | ||
| Q2 24 | $-8.6M | $1.2M | ||
| Q1 24 | $-19.1M | $-4.8M |
| Q4 25 | 291.6% | 12.7% | ||
| Q3 25 | — | 14.9% | ||
| Q2 25 | — | 6.5% | ||
| Q1 25 | — | -21.4% | ||
| Q4 24 | -39.6% | 5.2% | ||
| Q3 24 | -42.3% | 3.0% | ||
| Q2 24 | -44.9% | 2.3% | ||
| Q1 24 | -107.0% | -9.5% |
| Q4 25 | 18.9% | 11.5% | ||
| Q3 25 | — | 10.6% | ||
| Q2 25 | — | 12.9% | ||
| Q1 25 | — | 26.2% | ||
| Q4 24 | 92.3% | 19.5% | ||
| Q3 24 | 37.7% | 19.0% | ||
| Q2 24 | 39.7% | 16.3% | ||
| Q1 24 | 33.5% | 11.9% |
| Q4 25 | 2.50× | 3.27× | ||
| Q3 25 | 0.15× | 5.23× | ||
| Q2 25 | 4.59× | 3.88× | ||
| Q1 25 | 0.61× | 1.09× | ||
| Q4 24 | — | 3.47× | ||
| Q3 24 | -0.02× | 3.29× | ||
| Q2 24 | — | 6.94× | ||
| Q1 24 | — | 0.73× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ADAM
| Other | $19.6M | 45% |
| Constructive Loans LLC | $14.4M | 33% |
| Multifamily | $9.1M | 21% |
VMD
Segment breakdown not available.
